[2021 ASCO] 에이비온 발표 포스터

작성일

2023-08-23 13:46

Trial in progress: A phase 1-2 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of ABN401 in patients with advanced solid tumors.

« [2021 ESMO] 에이비온 발표 포스터

[2022 ESMO] 에이비온 발표 포스터 1 »

목록보기

NEWS

[2021 ASCO] 에이비온 발표 포스터